![William Young](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Young
Direktor/Vorstandsmitglied bei
AUTOLUS THERAPEUTICS PLC
Vermögen: 952 031 $ am 30.09.2026
Profil
William D.
Young is currently Director at Raven Biotechnologies, Inc., Director at SFJ Pharmaceuticals, Inc. since 2010, Independent Director at Praxis Precision Medicines, Inc. since 2016, Non-Executive Director at Autolus Therapeutics Plc since 2021, Member of the National Academy of Engineering, Senior Advisor at Blackstone, Inc. since 2009, and Trustee at Montage Health.
Formerly, Mr. Young was Chairman & Chief Executive Officer at Monogram Biosciences, Inc. from 2000 to 2009, Chairman at Biogen, Inc. in 2014, Chairman at AGY Therapeutics, Inc., Chairman at TYRX, Inc., Chairman at Annexon, Inc. from 2017 to 2021, Chairman-Emeritus at The Bay Area Bioscience Association, Chairman at NS Wind Down Co., Inc. from 2010 to 2024, Independent Director at Vertex Pharmaceuticals, Inc. from 2015 to 2020, Director at Human Genome Sciences, Inc. from 2003 to 2006, Independent Non-Executive Director at BioMarin Pharmaceutical, Inc. from 2010 to 2015, Director at VaxGen, Inc., Director at Receptor BioLogix, Inc., Director at IDEC Pharmaceuticals Corp., Independent Director at Innoviva, Inc. from 2011 to 2014, Director at Biogen Idec New Ventures, Inc. from 1997 to 2010, Director at Biogen Idec, Inc. (North Carolina) from 1997 to 2014, Independent Director at Ariosa Diagnostics, Inc., Director at Biomarine, Inc., Lead Independent Director at Theravance Biopharma, Inc. from 2013 to 2023, Chief Operating Officer at Genentech, Inc. from 1997 to 1999, Member-Supervisory Board at DHB Verwaltungs AG, Venture Partner at Clarus Ventures LLC from 2010 to 2018, and Senior Advisor at Blackstone Life Sciences Advisors LLC.
Education includes an MBA from Indiana University conferred in 1971 and an undergraduate degree from Purdue University conferred in 1966.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.06.2026 | 3.269 ( 0,01 % ) | 952 031 $ | 30.09.2026 | |
| 29.06.2026 | 0 ( -.--% ) | - $ | 30.09.2026 |
Aktive Positionen von William Young
| Unternehmen | Position | Beginn |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Direktor/Vorstandsmitglied | 01.12.2016 |
| BLACKSTONE INC. | Berater | 01.01.2009 |
| AUTOLUS THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 15.11.2021 |
SFJ Pharmaceuticals, Inc.
 SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops pharmaceuticals drugs | Direktor/Vorstandsmitglied | 01.01.2010 |
Montage Health
 Montage Health Miscellaneous Commercial ServicesCommercial Services Provides health care services | Direktor/Vorstandsmitglied | - |
National Academy of Engineering
 National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
Raven Biotechnologies, Inc.
 Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops antibody therapeutics | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von William Young
| Unternehmen | Position | Ende |
|---|---|---|
| NS WIND DOWN CO., INC. | Vorsitzender | 26.06.2024 |
| THERAVANCE BIOPHARMA | Direktor/Vorstandsmitglied | 01.02.2023 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von William Young
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
32
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 32 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes biologic products | Health Technology |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services for HIV treatment | Commercial Services |
AGY Therapeutics, Inc.
 AGY Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapies for diseases and disorders | Health Technology |
Receptor BioLogix, Inc.
 Receptor BioLogix, Inc. BiotechnologyHealth Technology Offers receptor based biological therapeutics | Health Technology |
TYRX, Inc.
 TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology Designs and manufactures medical-pharmaceutical combination devices | Electronic Technology |
Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops antibody therapeutics | Commercial Services |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
DHB Verwaltungs AG
 DHB Verwaltungs AG Finance/Rental/LeasingFinance Provides mortgage banking services | Finance |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NS Wind Down Co., Inc.
 NS Wind Down Co., Inc. Medical SpecialtiesHealth Technology Develops and manufactures life science tools for translational research and molecular diagnostic products | Health Technology |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences. | Finance |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
The Bay Area Bioscience Association
 The Bay Area Bioscience Association BiotechnologyHealth Technology Provides biomedical communities services | Health Technology |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Blackstone, Inc.
 Blackstone, Inc. Investment ManagersFinance Provides alternative asset management services | Finance |
Montage Health
Montage Health Miscellaneous Commercial ServicesCommercial Services Provides health care services | Commercial Services |
SFJ Pharmaceuticals, Inc.
SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops pharmaceuticals drugs | Health Technology |
Ariosa Diagnostics, Inc.
 Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Offers diagnostics and genetic testing services | Health Services |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Biomarine, Inc.
 Biomarine, Inc. Medical SpecialtiesHealth Technology Manufactures physicians and surgeons equipment and supplies | Health Technology |
Praxis Precision Medicines, Inc.
 Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions. | Finance |
